Fig. 1.
SARS-CoV-2 Mpro inhibitors reported in literature: PF-07304814; GC-376 and analogue 6j, MI-09 and analogue MI-30; peptidomimetic Mpro inhibitors N3 and 13b.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.